Table 2. The chemotherapy regimens (n=63).
Regimen | LCNEC (n=31) | SCLC (n=32) |
---|---|---|
Neoadjuvant setting (n=5) | ||
CDDP + CPT-11 | 0 | 1 |
CDDP + VP-16 | 0 | 3 |
CBDCA + VP-16 | 0 | 1 |
Adjuvant setting (n=58) | ||
CDDP + CPT-11 | 11 | 7 |
CDDP + VP-16 | 6 | 14 |
CBDCA + PTX | 6 | 0 |
CDDP + VNR | 5 | 1 |
CBDCA + VP-16 | 3 | 4 |
CBDCA + CPT-11 | 0 | 1 |
CDDP, cisplatin; CPT-11, irinotecan; CBDCA, carboplatin; VNR, vinorelbine; PTX, paclitaxel; VP16, etoposide.